Benzinga
16 Sept 2026, 09:04 UTC · 2h ago
Verdict
Headline leans bullish. We score TPST +1.00 across two claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+1.00strongly bullish
What the story claims
2 claims · scored −1 bearish … +1 bullish · 2 new · 0 priced in
Tempest Therapeutics entered an exclusive option agreement with Hebei Senlang Biotechnology to license a CD7-targeted lentiviral vector platform and an in vivo CAR-T pipeline.
Newannounced in the news cycle of Sep 16
So whatThe addition of a Phase 1 dual-targeting candidate for multiple myeloma diversifies the clinical-stage pipeline and may reduce binary risk for the company's valuation.
More positive than 98% of claims this week
Continue reading
5 related stories
More positive than 99% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Tempest Therapeutics shares rose 49.6% to $1.13 in pre-market trading following the licensing announcement.
Newpre-market trading on Sep 16
More positive than 77% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
Shares rose nearly 50% following an exclusive option agreement for a CAR-T pipeline.
More positive than 88% of ticker scores this week
Stock price is trading significantly higher in pre-market trading.
More negative than 83% of ticker scores this week
Stock price is trading significantly lower in pre-market trading.
More positive than 76% of ticker scores this week
Stock price is trading higher in pre-market trading.
More negative than 81% of ticker scores this week
Stock price is trading significantly lower in pre-market trading.
More positive than 70% of ticker scores this week
Stock price is trading higher in pre-market trading.
More positive than 66% of ticker scores this week
Stock price is trading higher in pre-market trading.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
6h ago
—
TPST hasn't traded since this ran. Last close $0.7554 (Sep 15); the reaction starts at the next open.
TPST chart →
